# ![@BioPharmaDive Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1564125781.png) @BioPharmaDive BioPharma Dive

BioPharma Dive posts on X about $nvo, $lly, $pfe, $bmy the most. They currently have [------] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

### Engagements: [-----] [#](/creator/twitter::1564125781/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1564125781/c:line/m:interactions.svg)

- [--] Week [-----] -24%
- [--] Month [------] +25%
- [--] Months [------] +24%
- [--] Year [-------] -20%

### Mentions: [--] [#](/creator/twitter::1564125781/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1564125781/c:line/m:posts_active.svg)

- [--] Month [--] +2%
- [--] Months [---] +21%
- [--] Year [---] +3.80%

### Followers: [------] [#](/creator/twitter::1564125781/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1564125781/c:line/m:followers.svg)

- [--] Week [------] +0.04%
- [--] Month [------] +0.19%
- [--] Months [------] +1.60%
- [--] Year [------] +3.20%

### CreatorRank: [-------] [#](/creator/twitter::1564125781/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1564125781/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  68.57% [finance](/list/finance)  8.57% [cryptocurrencies](/list/cryptocurrencies)  3.57% [currencies](/list/currencies)  2.86% [countries](/list/countries)  2.86% [technology brands](/list/technology-brands)  1.43%

**Social topic influence**
[$nvo](/topic/$nvo) 18.57%, [$lly](/topic/$lly) 10.71%, [$pfe](/topic/$pfe) 5.71%, [$bmy](/topic/$bmy) 4.29%, [sanofi](/topic/sanofi) #52, [$sny](/topic/$sny) #38, [$mrna](/topic/$mrna) #22, [$abbv](/topic/$abbv) 3.57%, [novartis](/topic/novartis) 3.57%, [$nvs](/topic/$nvs) 3.57%

**Top accounts mentioned or mentioned by**
[@benthefidler](/creator/undefined) [@lilahalvarado](/creator/undefined) [@byjongardner](/creator/undefined) [@realjacobbell](/creator/undefined) [@gwendolynawu](/creator/undefined) [@marcjacksonla](/creator/undefined) [@nedpagliarulo](/creator/undefined) [@stockwatch369](/creator/undefined) [@hansbangen](/creator/undefined) [@biosiryn](/creator/undefined) [@abatemanhouse](/creator/undefined) [@timcarmichael3](/creator/undefined) [@_janejlee](/creator/undefined) [@contrariansmind](/creator/undefined) [@archimedes20311](/creator/undefined) [@joecarlolaw](/creator/undefined) [@persimmonti](/creator/undefined)

**Top assets mentioned**
[Novo-Nordisk (NVO)](/topic/$nvo) [Eli Lilly and Company (LLY)](/topic/$lly) [Pfizer, Inc. (PFE)](/topic/$pfe) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Sanofi (SNY)](/topic/sanofi) [Synthetify (SNY)](/topic/$sny) [Moderna Inc (MRNA)](/topic/$mrna) [AbbVie Inc (ABBV)](/topic/$abbv) [Novartis AG (NVS)](/topic/novartis) [AstraZeneca PLC (AZN)](/topic/$azn) [GSK plc (GSK)](/topic/$gsk) [Johnson & Johnson (JNJ)](/topic/$jnj) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Valneva SE (VALN)](/topic/$valn) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Amgen, Inc. (AMGN)](/topic/$amgn) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [United Therapeutics, Corp. (UTHR)](/topic/$uthr) [Janux Therapeutics, Inc. (JANX)](/topic/$janx) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [SuperRare (RARE)](/topic/$rare) [Vertex Protocol (VRTX)](/topic/$vrtx) [Alkermes Inc. plc (ALKS)](/topic/$alks) [Atai Life Sciences B.V. (ATAI)](/topic/$atai) [Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova) [Arvinas, Inc (ARVN)](/topic/$arvn) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Novavax Inc (NVAX)](/topic/$nvax) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Roivant Sciences Ltd. Common Shares (ROIV)](/topic/$roiv) [Biogen Inc (BIIB)](/topic/$biib) [Lazard Ltd. Class A (LAZ)](/topic/$laz) [Akropolis (AKRO)](/topic/$akro)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Sanofi looking for more rigor swaps CEO Hudson for ex-Merck KGaA chief Garijo $SNY By Kristin Jensen https://www.biopharmadive.com/news/sanofi-ceo-paul-hudson-belen-garijo/812061/ https://www.biopharmadive.com/news/sanofi-ceo-paul-hudson-belen-garijo/812061/"  
[X Link](https://x.com/BioPharmaDive/status/2021982434393567323)  2026-02-12T16:19Z 13.7K followers, [---] engagements


"Valneva to withdraw Chikungunya vaccine from US amid safety woes $VALN by @Lilah_Alvarado https://www.biopharmadive.com/news/valneva-fda-withdrawl-application-chikungunya-Ixchiq-vaccine/809994/ https://www.biopharmadive.com/news/valneva-fda-withdrawl-application-chikungunya-Ixchiq-vaccine/809994/"  
[X Link](https://x.com/BioPharmaDive/status/2013692370206761058)  2026-01-20T19:17Z 13.7K followers, [---] engagements


"BioMarin vets form Mendra to modernize rare disease drug development $BMRN by Kristin Jensen https://www.biopharmadive.com/news/mendra-rare-disease-biotech-startup-ai-biomarin-financing/810204/ https://www.biopharmadive.com/news/mendra-rare-disease-biotech-startup-ai-biomarin-financing/810204/"  
[X Link](https://x.com/BioPharmaDive/status/2014373518125789285)  2026-01-22T16:24Z 13.7K followers, [---] engagements


"Bristol Myers buys into Januxs masked T cell engagers $BMY $JANX by @Lilah_Alvarado https://www.biopharmadive.com/news/janux-bristol-myers-partnership-t-cell-engagers-cancer/810227/ https://www.biopharmadive.com/news/janux-bristol-myers-partnership-t-cell-engagers-cancer/810227/"  
[X Link](https://x.com/BioPharmaDive/status/2014408639138717801)  2026-01-22T18:43Z 13.7K followers, [---] engagements


"Sarepta battling slowing sales claims Duchenne gene therapys impact grows with time $SRPT @ByJonGardner https://www.biopharmadive.com/news/sarepta-elevidys-duchenne-gene-therapy-embark-data/810461/ https://www.biopharmadive.com/news/sarepta-elevidys-duchenne-gene-therapy-embark-data/810461/"  
[X Link](https://x.com/BioPharmaDive/status/2015851830735970660)  2026-01-26T18:18Z 13.7K followers, [---] engagements


"AstraZeneca leans into obesity striking wide-ranging alliance with Chinas CSPC $AZN by @BentheFidler https://www.biopharmadive.com/news/astrazeneca-obesity-deal-china-cspc-ai/810942/ https://www.biopharmadive.com/news/astrazeneca-obesity-deal-china-cspc-ai/810942/"  
[X Link](https://x.com/BioPharmaDive/status/2017282284764778835)  2026-01-30T17:02Z 13.7K followers, [---] engagements


"Amgen gives up on its once-prized eczema drug $AMGN @ByJonGardner https://www.biopharmadive.com/news/amgen-return-rocatinlimab-kyowa-kirin-atopic-dermatitis-eczma-ox40/810964/ https://www.biopharmadive.com/news/amgen-return-rocatinlimab-kyowa-kirin-atopic-dermatitis-eczma-ox40/810964/"  
[X Link](https://x.com/BioPharmaDive/status/2017312657963958719)  2026-01-30T19:03Z 13.7K followers, [---] engagements


"Earnings roundup: Amgen vs. FDA Pfizers defense and Mercks $70B-in-sales plan $PFE $AMGN $MRK https://www.biopharmadive.com/news/amgen-pfizer-merck-fda-biotech-earnings-q4-2025/811287/ https://www.biopharmadive.com/news/amgen-pfizer-merck-fda-biotech-earnings-q4-2025/811287/"  
[X Link](https://x.com/BioPharmaDive/status/2019083920894026189)  2026-02-04T16:21Z 13.7K followers, [---] engagements


"Lilly soars again as fast-selling weight loss drugs top Wall Street projections $LLY by Kristin Jensen https://www.biopharmadive.com/news/lilly-earnings-guidance-q4-2025-obesity-drugs/811317/ https://www.biopharmadive.com/news/lilly-earnings-guidance-q4-2025-obesity-drugs/811317/"  
[X Link](https://x.com/BioPharmaDive/status/2019095977223766247)  2026-02-04T17:09Z 13.7K followers, [---] engagements


"Novo shares tumble by double digits on grim sales outlook $NVO @ByJonGardner https://www.biopharmadive.com/news/novo-nordisk-2025-earnings-2026-outlook/811318/ https://www.biopharmadive.com/news/novo-nordisk-2025-earnings-2026-outlook/811318/"  
[X Link](https://x.com/BioPharmaDive/status/2019115830358032548)  2026-02-04T18:28Z 13.7K followers, [---] engagements


"Generate an AI-driven Flagship startup pitches an IPO By Kristin Jensen https://www.biopharmadive.com/news/generate-biomedicines-ipo-flagship-ai-tlsp/811482/ https://www.biopharmadive.com/news/generate-biomedicines-ipo-flagship-ai-tlsp/811482/"  
[X Link](https://x.com/BioPharmaDive/status/2019454731488297157)  2026-02-05T16:55Z 13.7K followers, [---] engagements


"Novo Lilly sputter as Hims launches knockoff GLP-1 pill $NVO $LLY by @BentheFidler https://www.biopharmadive.com/news/hims-compounded-wegovy-glp-1-obesity-novo-lilly/811476/ https://www.biopharmadive.com/news/hims-compounded-wegovy-glp-1-obesity-novo-lilly/811476/"  
[X Link](https://x.com/BioPharmaDive/status/2019503656819646672)  2026-02-05T20:09Z 13.7K followers, [---] engagements


"AstraZeneca strengthens China ties with planned $15B investment $AZN by Kristin Jensen https://www.biopharmadive.com/news/astrazeneca-china-biotech-invest-drug-manufacturing/810847/ https://www.biopharmadive.com/news/astrazeneca-china-biotech-invest-drug-manufacturing/810847/"  
[X Link](https://x.com/BioPharmaDive/status/2016921041646256558)  2026-01-29T17:07Z 13.7K followers, [---] engagements


"FDA rejects Regenxbio treatment in another blow to gene therapy $RGNX by @gwendolynawu https://www.biopharmadive.com/news/regenxbio-fda-reject-gene-therapy-mps-hunter-syndrome/811775/ https://www.biopharmadive.com/news/regenxbio-fda-reject-gene-therapy-mps-hunter-syndrome/811775/"  
[X Link](https://x.com/anyuser/status/2021274864204808615)  2026-02-10T17:27Z 13.7K followers, [---] engagements


"Earnings roundup: Neurocrine slumps Alnylam battles skeptics and Ascendis eyes a competitor $NBIX $ALNY $ASND by @realJacobBell https://www.biopharmadive.com/news/alnylam-neurocrine-ascendis-biotech-earnings-4q-2025/812137/ https://www.biopharmadive.com/news/alnylam-neurocrine-ascendis-biotech-earnings-4q-2025/812137/"  
[X Link](https://x.com/BioPharmaDive/status/2022360018042130840)  2026-02-13T17:19Z 13.7K followers, [---] engagements


"Lilly buys in vivo CAR-T maker Orna extending streak of genetic medicine deals $LLY @ByJonGardner https://www.biopharmadive.com/news/lilly-orna-acquire-in-vivo-cell-therapy-autoimmune/811692/ https://www.biopharmadive.com/news/lilly-orna-acquire-in-vivo-cell-therapy-autoimmune/811692/"  
[X Link](https://x.com/anyuser/status/2020909979524321328)  2026-02-09T17:17Z 13.7K followers, [---] engagements


"Madrigal turns to RNAi drugs from China to bolster MASH pipeline $MDGL by Kristin Jensen https://www.biopharmadive.com/news/madrigal-suzhou-ribo-mash-rnai-drug-deal-china/811920/ https://www.biopharmadive.com/news/madrigal-suzhou-ribo-mash-rnai-drug-deal-china/811920/"  
[X Link](https://x.com/BioPharmaDive/status/2021627017146642572)  2026-02-11T16:46Z 13.7K followers, [---] engagements


"News Roundup: Evommune rockets on eczema data; AstraZeneca advances GLP-1 pill https://www.biopharmadive.com/news/evommune-eczema-astrazeneca-obesity-upstream-takeda-oveporexton-moderna/811791/ https://www.biopharmadive.com/news/evommune-eczema-astrazeneca-obesity-upstream-takeda-oveporexton-moderna/811791/"  
[X Link](https://x.com/BioPharmaDive/status/2021649081677041683)  2026-02-11T18:14Z 13.7K followers, [---] engagements


"BridgeBio scores with dwarfism drug setting up showdown with BioMarin Ascendis $BBIO $BMRN $ASND by @realJacobBell https://www.biopharmadive.com/news/bridgebio-dwarfism-drug-data-infigratinib-achondroplasia-biomarin-ascendis/812034/ https://www.biopharmadive.com/news/bridgebio-dwarfism-drug-data-infigratinib-achondroplasia-biomarin-ascendis/812034/"  
[X Link](https://x.com/BioPharmaDive/status/2021994146740019387)  2026-02-12T17:05Z 13.7K followers, [---] engagements


"Moderna shares jump as company affirms growth outlook $MRNA by @Lilah_Alvarado https://www.biopharmadive.com/news/moderna-fourth-quarter-2025-financial-earnings/812211/ https://www.biopharmadive.com/news/moderna-fourth-quarter-2025-financial-earnings/812211/"  
[X Link](https://x.com/BioPharmaDive/status/2022370319835467957)  2026-02-13T18:00Z 13.7K followers, [---] engagements


"News roundup: Lilly bets again on China drugs; Roche showcases MS data https://www.biopharmadive.com/news/lilly-bets-again-on-china-drugs-roche-showcases-ms-data/811669/ https://www.biopharmadive.com/news/lilly-bets-again-on-china-drugs-roche-showcases-ms-data/811669/"  
[X Link](https://x.com/BioPharmaDive/status/2020926088818704501)  2026-02-09T18:21Z 13.7K followers, [---] engagements


"FDA removes box warning for [--] menopausal therapies by @Lilah_Alvarado https://www.biopharmadive.com/news/fda-removes-box-warning-six-menopausal-therapies-hrt/812146/ https://www.biopharmadive.com/news/fda-removes-box-warning-six-menopausal-therapies-hrt/812146/"  
[X Link](https://x.com/BioPharmaDive/status/2022346337509834993)  2026-02-13T16:25Z 13.7K followers, [---] engagements


"Ultragenyx cuts jobs as it seeks path to profit in [----] $RARE @ByJonGardner https://www.biopharmadive.com/news/ultragenyx-cuts-jobs-profitability-earnings-2025-gene-therapy/812204/ https://www.biopharmadive.com/news/ultragenyx-cuts-jobs-profitability-earnings-2025-gene-therapy/812204/"  
[X Link](https://x.com/BioPharmaDive/status/2022386699708567753)  2026-02-13T19:05Z 13.7K followers, [---] engagements


"News Roundup: Novo climbs higher on strong Wegovy pill launch; Terns tweaks leukemia drug deal https://www.biopharmadive.com/news/wegovy-pill-prescriptions-terns-deal-corcept-data-biomerieux/810253/ https://www.biopharmadive.com/news/wegovy-pill-prescriptions-terns-deal-corcept-data-biomerieux/810253/"  
[X Link](https://x.com/BioPharmaDive/status/2014795559266111835)  2026-01-23T20:21Z 13.7K followers, [---] engagements


"Regenxbio gene therapy trials suspended by FDA over safety worries $RGNX By Kristin Jensen https://www.biopharmadive.com/news/regenxbio-fda-hold-hunter-hurler-syndrome-gene-therapy/810691/ https://www.biopharmadive.com/news/regenxbio-fda-hold-hunter-hurler-syndrome-gene-therapy/810691/"  
[X Link](https://x.com/BioPharmaDive/status/2016564356222193707)  2026-01-28T17:29Z 13.7K followers, [---] engagements


"GSK walks away from pioneering Wave RNA editing drug $GSK by @BentheFidler https://www.biopharmadive.com/news/wave-gsk-reacquire-rna-editing-drug-aatd/811067/ https://www.biopharmadive.com/news/wave-gsk-reacquire-rna-editing-drug-aatd/811067/"  
[X Link](https://x.com/BioPharmaDive/status/2018374346864009558)  2026-02-02T17:21Z 13.7K followers, [---] engagements


"Eikon Therapeutics nets a $381M IPO amid burst of biotech offerings $EIKN by @gwendolynawu https://www.biopharmadive.com/news/eikon-biotech-ipo-price-cancer-drugs-2026/811169/ https://www.biopharmadive.com/news/eikon-biotech-ipo-price-cancer-drugs-2026/811169/"  
[X Link](https://x.com/BioPharmaDive/status/2019432647261565345)  2026-02-05T15:27Z 13.7K followers, [---] engagements


"Bayer details anticipated stroke prevention data for new blood-thinner $BAYRY @ByJonGardner https://www.biopharmadive.com/news/bayer-asundexian-factorXIa-secondary-stroke-data-conference/811455/ https://www.biopharmadive.com/news/bayer-asundexian-factorXIa-secondary-stroke-data-conference/811455/"  
[X Link](https://x.com/BioPharmaDive/status/2019467063853490579)  2026-02-05T17:44Z 13.7K followers, [---] engagements


"Sanofi expects vaccine sales growth to dip amid challenging environment $SNY by @Lilah_Alvarado https://www.biopharmadive.com/news/sanofi-vaccine-sales-fourth-quarter-2025-earnings/810829/ https://www.biopharmadive.com/news/sanofi-vaccine-sales-fourth-quarter-2025-earnings/810829/"  
[X Link](https://x.com/BioPharmaDive/status/2016936533283020974)  2026-01-29T18:08Z 13.7K followers, [---] engagements


"Sanofi drug inherited from Genzyme goes 1-for-2 in rare disease trials $SNY by @Lilah_Alvarado https://www.biopharmadive.com/news/sanofi-venglustat-gaucher-fabry-study-results/811113/ https://www.biopharmadive.com/news/sanofi-venglustat-gaucher-fabry-study-results/811113/"  
[X Link](https://x.com/BioPharmaDive/status/2018394702773432451)  2026-02-02T18:42Z 13.7K followers, [---] engagements


"Earnings roundup: AbbVie angst a bifurcated vaccine market and Bristol Myers waiting game $BMY $GSK $ABBV https://www.biopharmadive.com/news/bristol-myers-abbvie-gsk-vaccines-biotech-earnings-q4-2025/811463/ https://www.biopharmadive.com/news/bristol-myers-abbvie-gsk-vaccines-biotech-earnings-q4-2025/811463/"  
[X Link](https://x.com/BioPharmaDive/status/2019532339102265395)  2026-02-05T22:03Z 13.7K followers, [---] engagements


"White Houses online service for drug sales debuts with limited impact on prices @ByJonGardner https://www.biopharmadive.com/news/trump-rx-drug-prices-discount-white-house/811576/ https://www.biopharmadive.com/news/trump-rx-drug-prices-discount-white-house/811576/"  
[X Link](https://x.com/BioPharmaDive/status/2019837257285587199)  2026-02-06T18:15Z 13.7K followers, [---] engagements


"Hims cancels plans to sell compounded GLP-1 pill after FDA backlash $NVO by @BentheFidler https://www.biopharmadive.com/news/hims-stop-launch-compounded-wegovy-fda-novo/811662/ https://www.biopharmadive.com/news/hims-stop-launch-compounded-wegovy-fda-novo/811662/"  
[X Link](https://x.com/BioPharmaDive/status/2020891231006437783)  2026-02-09T16:03Z 13.7K followers, [---] engagements


"Hengrui Kailera tout positive results for dual-acting obesity pill by @Lilah_Alvarado https://www.biopharmadive.com/news/kailera-hengrui-oral-ribupatide-study-results-china/811718/ https://www.biopharmadive.com/news/kailera-hengrui-oral-ribupatide-study-results-china/811718/"  
[X Link](https://x.com/BioPharmaDive/status/2021267028904976619)  2026-02-10T16:56Z 13.7K followers, [---] engagements


"Gilead dips as strong earnings outweighed by high expectations for new HIV drug $GILD by @realJacobBell https://www.biopharmadive.com/news/gilead-yeztugo-earnings-q4-full-year-hiv-sales/811908/ https://www.biopharmadive.com/news/gilead-yeztugo-earnings-q4-full-year-hiv-sales/811908/"  
[X Link](https://x.com/BioPharmaDive/status/2021597878137884801)  2026-02-11T14:51Z 13.7K followers, [---] engagements


"FDA refuses to review Modernas mRNA flu vaccine $MRNA by @Lilah_Alvarado https://www.biopharmadive.com/news/moderna-fda-influenza-mrna-refuse-to-file/811909/ https://www.biopharmadive.com/news/moderna-fda-influenza-mrna-refuse-to-file/811909/"  
[X Link](https://x.com/BioPharmaDive/status/2021610386747772937)  2026-02-11T15:40Z 13.7K followers, [---] engagements


"Seres to lay off staff pause top program in latest reboot $MCRB by @Lilah_Alvarado https://www.biopharmadive.com/news/seres-layoffs-restructuring-microbiome-immune-disease/812079/ https://www.biopharmadive.com/news/seres-layoffs-restructuring-microbiome-immune-disease/812079/"  
[X Link](https://x.com/BioPharmaDive/status/2022017777360666770)  2026-02-12T18:39Z 13.7K followers, [---] engagements


"Dont miss our in-depth look at whats ahead for biotech and pharma in [----]. From groundbreaking therapies to regulatory updates discover the trends that will define the industry. Get the free report: https://www.biopharmadive.com/news/biotech-pharma-trends-outlook-2026/810833/utm_source=twitter&utm_medium=organic-social&utm_campaign=BioPharma-Dive-Twitter-pinned-post-AG-Outlook2026 https://www.biopharmadive.com/news/biotech-pharma-trends-outlook-2026/810833/utm_source=twitter&utm_medium=organic-social&utm_campaign=BioPharma-Dive-Twitter-pinned-post-AG-Outlook2026"  
[X Link](https://x.com/BioPharmaDive/status/2022350249281622261)  2026-02-13T16:40Z 13.7K followers, [---] engagements


"Nektar continuing comeback says eczema drugs effects hold up in follow-up study $NKTR @ByJonGardner https://www.biopharmadive.com/news/nektar-rezpegaldesleukin-eczema-maintenance-data-results/811806/ https://www.biopharmadive.com/news/nektar-rezpegaldesleukin-eczema-maintenance-data-results/811806/"  
[X Link](https://x.com/BioPharmaDive/status/2021289948934996318)  2026-02-10T18:27Z 13.7K followers, [---] engagements


"Vertexs CRISPR therapy rebounds in latest earnings $VRTX by @gwendolynawu https://www.biopharmadive.com/news/vertex-earnings-casgevy-q4-2025/812243/ https://www.biopharmadive.com/news/vertex-earnings-casgevy-q4-2025/812243/"  
[X Link](https://x.com/BioPharmaDive/status/2022409812093604352)  2026-02-13T20:37Z 13.7K followers, [---] engagements


"5 questions on Sarepta the FDA and a Duchenne gene therapy crisis $SRPT by @NedPagliarulo @BentheFidler https://www.biopharmadive.com/news/sarepta-fda-elevidys-duchenne-gene-therapy-crisis-questions/753515/ https://www.biopharmadive.com/news/sarepta-fda-elevidys-duchenne-gene-therapy-crisis-questions/753515/"  
[X Link](https://x.com/BioPharmaDive/status/1947343339222683797)  2025-07-21T17:10Z 13.4K followers, [---] engagements


"Alkermes narcolepsy drug headed for late-stage testing $ALKS by @realJacobBell https://www.biopharmadive.com/news/alkermes-phase-2-narcolepsy-data-orexin/753540/ https://www.biopharmadive.com/news/alkermes-phase-2-narcolepsy-data-orexin/753540/"  
[X Link](https://x.com/BioPharmaDive/status/1947360521205719041)  2025-07-21T18:18Z 13.5K followers, [---] engagements


"AstraZeneca grows US presence with $50B in spending plans $AZN by @NedPagliarulo https://www.biopharmadive.com/news/astrazeneca-manufacturing-us-virgina-invest-trump-tariffs/753642/ https://www.biopharmadive.com/news/astrazeneca-manufacturing-us-virgina-invest-trump-tariffs/753642/"  
[X Link](https://x.com/BioPharmaDive/status/1947682553311162591)  2025-07-22T15:38Z 13.4K followers, [---] engagements


"News Roundup: Replimune drug rejected by FDA; Omega raises $647M biotech fund https://www.biopharmadive.com/news/replimune-fda-rejection-icotrokinra-filing-omega-funds-raise/753599/ https://www.biopharmadive.com/news/replimune-fda-rejection-icotrokinra-filing-omega-funds-raise/753599/"  
[X Link](https://x.com/BioPharmaDive/status/1947720207566344670)  2025-07-22T18:07Z 13.5K followers, [---] engagements


"Dispatch emerges with $216M and plans for a universal solid tumor therapy by @BentheFidler https://www.biopharmadive.com/news/disptach-bio-universal-cancer-immunotherapy-solid-tumors/753743/ https://www.biopharmadive.com/news/disptach-bio-universal-cancer-immunotherapy-solid-tumors/753743/"  
[X Link](https://x.com/BioPharmaDive/status/1948024635720884610)  2025-07-23T14:17Z 13.5K followers, [---] engagements


"Roche stops shipping Sarepta gene therapy in some countries outside US $RHHBY by @NedPagliarulo https://www.biopharmadive.com/news/roche-elevidys-pause-some-shipments-duchenne-sarepta/753817/ https://www.biopharmadive.com/news/roche-elevidys-pause-some-shipments-duchenne-sarepta/753817/"  
[X Link](https://x.com/BioPharmaDive/status/1948069023994003951)  2025-07-23T17:13Z 13.4K followers, [---] engagements


"In reversal European regulators take positive view on Lilly Alzheimers drug $LLY by @realJacobBell https://www.biopharmadive.com/news/eli-lilly-ema-donanemab-kisunla-positive-opinion-review/754066/ https://www.biopharmadive.com/news/eli-lilly-ema-donanemab-kisunla-positive-opinion-review/754066/"  
[X Link](https://x.com/BioPharmaDive/status/1948762224635367648)  2025-07-25T15:08Z 13.4K followers, [---] engagements


"Bristol Myers shuffles its executive ranks with new CMO $BMY by @gwendolynawu https://www.biopharmadive.com/news/bristol-myers-cmo-massacesi-hirawat-succeed/754063/ https://www.biopharmadive.com/news/bristol-myers-cmo-massacesi-hirawat-succeed/754063/"  
[X Link](https://x.com/BioPharmaDive/status/1948779685116064055)  2025-07-25T16:17Z 13.4K followers, [---] engagements


"News Roundup: Rocket lays off staff; Abivax capitalizes on immune drug data https://www.biopharmadive.com/news/rocket-layoffs-abivax-raise-novartis-matchpoint-lilly-gate/753921/ https://www.biopharmadive.com/news/rocket-layoffs-abivax-raise-novartis-matchpoint-lilly-gate/753921/"  
[X Link](https://x.com/BioPharmaDive/status/1948794588740956525)  2025-07-25T17:16Z 13.4K followers, [---] engagements


"Atai backs away from schizophrenia drug after trial failure $ATAI by @realJacobBell https://www.biopharmadive.com/news/atai-recognify-trial-failure-cognition-schizophrenia-drug/754184/ https://www.biopharmadive.com/news/atai-recognify-trial-failure-cognition-schizophrenia-drug/754184/"  
[X Link](https://x.com/BioPharmaDive/status/1949869234797912141)  2025-07-28T16:27Z 13.5K followers, [---] engagements


"GSK pays $500M to enter drugmaking alliance with Hengrui $GSK by @BentheFidler https://www.biopharmadive.com/news/gsk-hengrui-collaboration-copd-immunology-cancer-drugs/754161/ https://www.biopharmadive.com/news/gsk-hengrui-collaboration-copd-immunology-cancer-drugs/754161/"  
[X Link](https://x.com/BioPharmaDive/status/1949884407285723605)  2025-07-28T17:27Z 13.5K followers, [---] engagements


"Bain leads $300M investment in startup built on Bristol Myers immune drugs $BMY by @BentheFidler https://www.biopharmadive.com/news/bain-capital-bristol-myers-immune-drug-biotech-startup-launch/756121/ https://www.biopharmadive.com/news/bain-capital-bristol-myers-immune-drug-biotech-startup-launch/756121/"  
[X Link](https://x.com/BioPharmaDive/status/1950197805521277385)  2025-07-29T14:12Z 13.5K followers, [---] engagements


"Merck plans spending shift to boost business beyond Keytruda $MRK @ByJonGardner https://www.biopharmadive.com/news/merck-cost-cuts-spending-keytruda-earnings-q2/756152/ https://www.biopharmadive.com/news/merck-cost-cuts-spending-keytruda-earnings-q2/756152/"  
[X Link](https://x.com/BioPharmaDive/status/1950233764480897548)  2025-07-29T16:35Z 13.4K followers, [---] engagements


"News Roundup: Madrigal buys into GLP-1 from CSPC; Apellis wins expanded drug approval https://www.biopharmadive.com/news/madrigal-buys-into-glp-1-from-cspc-apellis-wins-expanded-drug-approval/756262/ https://www.biopharmadive.com/news/madrigal-buys-into-glp-1-from-cspc-apellis-wins-expanded-drug-approval/756262/"  
[X Link](https://x.com/BioPharmaDive/status/1950613894289903811)  2025-07-30T17:46Z 13.4K followers, [---] engagements


"Moderna to lay off 10% of workforce in difficult but necessary step $MRNA by @Lilah_Alvarado https://www.biopharmadive.com/news/moderna-layoffs-restructuring-expense-cuts-vaccine-sales/756415/ https://www.biopharmadive.com/news/moderna-layoffs-restructuring-expense-cuts-vaccine-sales/756415/"  
[X Link](https://x.com/BioPharmaDive/status/1950954765203988746)  2025-07-31T16:20Z 13.4K followers, [---] engagements


"In rumored AbbVie deal Wall Street sees momentum for psychedelics M&A $ABBV by @realJacobBell https://www.biopharmadive.com/news/psychedelics-dealmaking-wall-street-abbvie-gilgamesh/756496/ https://www.biopharmadive.com/news/psychedelics-dealmaking-wall-street-abbvie-gilgamesh/756496/"  
[X Link](https://x.com/BioPharmaDive/status/1951307071111954556)  2025-08-01T15:40Z 13.5K followers, [---] engagements


"Alnylam reaches new highs on strong sales of closely watched rare disease drug $ALNY by @BentheFidler https://www.biopharmadive.com/news/alnylam-amvuttra-q2-2025-sales-ttr-cardiomyopathy-guidance/756477/ https://www.biopharmadive.com/news/alnylam-amvuttra-q2-2025-sales-ttr-cardiomyopathy-guidance/756477/"  
[X Link](https://x.com/BioPharmaDive/status/1951320017896620282)  2025-08-01T16:32Z 13.5K followers, [---] engagements


"News Roundup: Regeneron cancer bispecific rejected again; Allogene discloses trial death https://www.biopharmadive.com/news/regeneron-odronextamab-crl-allogene-patient-death-bristol-myers-earnings/756464/ https://www.biopharmadive.com/news/regeneron-odronextamab-crl-allogene-patient-death-bristol-myers-earnings/756464/"  
[X Link](https://x.com/BioPharmaDive/status/1951332756421513248)  2025-08-01T17:22Z 13.5K followers, [---] engagements


"Gates Foundation pledges $2.5B toward womens health research by @Lilah_Alvarado https://www.biopharmadive.com/news/gates-foundation-women-health-investment-billion/756690/ https://www.biopharmadive.com/news/gates-foundation-women-health-investment-billion/756690/"  
[X Link](https://x.com/BioPharmaDive/status/1952737257175085566)  2025-08-05T14:23Z 13.5K followers, [---] engagements


"US biotech needs government support to match Chinas gains Pfizer CEO says $PFE by @BentheFidler https://www.biopharmadive.com/news/china-biotech-drug-deals-pfizer-bourla-comments/756880/ https://www.biopharmadive.com/news/china-biotech-drug-deals-pfizer-bourla-comments/756880/"  
[X Link](https://x.com/BioPharmaDive/status/1953129763398193426)  2025-08-06T16:23Z 13.5K followers, [---] engagements


"Novo pushes back against obesity drug compounders as competition intensifies $NVO @ByJonGardner https://www.biopharmadive.com/news/novo-nordisk-wegovy-obesity-compounders-second-quarter-2025-earnings/756916/ https://www.biopharmadive.com/news/novo-nordisk-wegovy-obesity-compounders-second-quarter-2025-earnings/756916/"  
[X Link](https://x.com/BioPharmaDive/status/1953136197414355270)  2025-08-06T16:48Z 13.5K followers, [---] engagements


"Iovance cuts staff amid slow sales start for TIL cell therapy $IOVA by @BentheFidler https://www.biopharmadive.com/news/iovance-layoffs-restructuring-amtagvi-sales-guidance/757041/ https://www.biopharmadive.com/news/iovance-layoffs-restructuring-amtagvi-sales-guidance/757041/"  
[X Link](https://x.com/BioPharmaDive/status/1953486241594307056)  2025-08-07T15:59Z 13.5K followers, [---] engagements


"FDA lifts pause on Valnevas chikungunya shot but adds new limits $VALN by @Lilah_Alvarado https://www.biopharmadive.com/news/valneva-chikungunya-vaccine-Ixchiq-pause-lifted-fda-restrictions-labeling/757080/ https://www.biopharmadive.com/news/valneva-chikungunya-vaccine-Ixchiq-pause-lifted-fda-restrictions-labeling/757080/"  
[X Link](https://x.com/BioPharmaDive/status/1953515005996892619)  2025-08-07T17:54Z 13.5K followers, [---] engagements


"Arvinas Pfizer reworking partnership on Protac cancer drug $PFE $ARVN By Kristin Jensen https://www.biopharmadive.com/news/arvinas-pfizer-vepdegestrant-partnership-rework-breast-cancer/757043/ https://www.biopharmadive.com/news/arvinas-pfizer-vepdegestrant-partnership-rework-breast-cancer/757043/"  
[X Link](https://x.com/BioPharmaDive/status/1953533227018133669)  2025-08-07T19:06Z 13.5K followers, [---] engagements


"Novartis drug acquired in Morphosys deal succeeds against tough-to-treat autoimmune disease $NVS by @BentheFidler https://www.biopharmadive.com/news/novartis-ianalumab-sjogrens-morphosys-study-results/757274/ https://www.biopharmadive.com/news/novartis-ianalumab-sjogrens-morphosys-study-results/757274/"  
[X Link](https://x.com/BioPharmaDive/status/1954934434114777475)  2025-08-11T15:54Z 13.5K followers, [---] engagements


"Pfizer looks to expand ADC use after positive bladder cancer data $PFE @ByJonGardner https://www.biopharmadive.com/news/padcev-keytruda-neoadjuvant-adjuvant-bladder-cancer-positive-data-pfizer-merck/757441/ https://www.biopharmadive.com/news/padcev-keytruda-neoadjuvant-adjuvant-bladder-cancer-positive-data-pfizer-merck/757441/"  
[X Link](https://x.com/BioPharmaDive/status/1955307259803603348)  2025-08-12T16:35Z 13.5K followers, [---] engagements


"News Roundup: Bayer buys into KRAS cancer drug; Novartis immune therapy goes [--] for [--] https://www.biopharmadive.com/news/bayer-buys-into-kras-cancer-drug-novartis-immune-therapy-goes-3-for-3/757400/ https://www.biopharmadive.com/news/bayer-buys-into-kras-cancer-drug-novartis-immune-therapy-goes-3-for-3/757400/"  
[X Link](https://x.com/BioPharmaDive/status/1955337374990241989)  2025-08-12T18:35Z 13.5K followers, [---] engagements


"AbbVie to build API plant in Illinois as it steps up US production $ABBV By Kristin Jensen https://www.biopharmadive.com/news/abbvie-api-manufacturing-plant-illinois-build/757524/ https://www.biopharmadive.com/news/abbvie-api-manufacturing-plant-illinois-build/757524/"  
[X Link](https://x.com/BioPharmaDive/status/1955651717208670360)  2025-08-13T15:24Z 13.5K followers, [---] engagements


"Vedanta PureTechs microbiome startup to cut staff after study setback by @BentheFidler https://www.biopharmadive.com/news/vedanta-layoffs-ulcerative-colitis-study-results-microbiome-puretech/757650/ https://www.biopharmadive.com/news/vedanta-layoffs-ulcerative-colitis-study-results-microbiome-puretech/757650/"  
[X Link](https://x.com/BioPharmaDive/status/1956025249935307108)  2025-08-14T16:08Z 13.5K followers, [---] engagements


"Novos Wegovy becomes first GLP-1 drug approved for MASH $NVO by @BentheFidler https://www.biopharmadive.com/news/novo-wegovy-mash-fda-approval-rezdiffra-madrigal/757853/ https://www.biopharmadive.com/news/novo-wegovy-mash-fda-approval-rezdiffra-madrigal/757853/"  
[X Link](https://x.com/BioPharmaDive/status/1957475012941693087)  2025-08-18T16:09Z 13.5K followers, [---] engagements


"Gilead dives into in vivo cell therapy with $350M buyout of Interius $GILD @ByJonGardner https://www.biopharmadive.com/news/gilead-interius-acquire-in-vivo-cell-therapy/758266/ https://www.biopharmadive.com/news/gilead-interius-acquire-in-vivo-cell-therapy/758266/"  
[X Link](https://x.com/BioPharmaDive/status/1958568687062958447)  2025-08-21T16:35Z 13.5K followers, [---] engagements


"AbbVie wagers more than $1B on Gilgameshs psychedelic drug $ABBV by @realJacobBell https://www.biopharmadive.com/news/abbvie-gilgamesh-psychedelic-drug-asset-deal-acquisition/758522/ https://www.biopharmadive.com/news/abbvie-gilgamesh-psychedelic-drug-asset-deal-acquisition/758522/"  
[X Link](https://x.com/BioPharmaDive/status/1960050823045759410)  2025-08-25T18:45Z 13.5K followers, [---] engagements


"RNA drug from Regeneron Alnylam succeeds in rare autoimmune disease trial $ALNY $REGN by @NedPagliarulo https://www.biopharmadive.com/news/regeneron-myasthenia-gravis-cemdisiran-alnylam-study-results/758607/ https://www.biopharmadive.com/news/regeneron-myasthenia-gravis-cemdisiran-alnylam-study-results/758607/"  
[X Link](https://x.com/BioPharmaDive/status/1960373055399612591)  2025-08-26T16:05Z 13.5K followers, [---] engagements


"Lilly says breast cancer drug extended survival in study $LLY by @Lilah_Alvarado https://www.biopharmadive.com/news/lilly-verzenio-survival-data-breast-cancer-monarche-study/758751/ https://www.biopharmadive.com/news/lilly-verzenio-survival-data-breast-cancer-monarche-study/758751/"  
[X Link](https://x.com/BioPharmaDive/status/1960750157089399077)  2025-08-27T17:04Z 13.5K followers, [---] engagements


"News Roundup: Amylyx drug comes up short; Sanofi names new CMO https://www.biopharmadive.com/news/amylyx-psp-results-sanofi-marcia-kayath-novartis-bioarctic/758697/ https://www.biopharmadive.com/news/amylyx-psp-results-sanofi-marcia-kayath-novartis-bioarctic/758697/"  
[X Link](https://x.com/BioPharmaDive/status/1960761238876508559)  2025-08-27T17:48Z 13.5K followers, [---] engagements


"FDA approves updated COVID boosters but narrows use $NVAX $MRNA $PFE by @Lilah_Alvarado https://www.biopharmadive.com/news/covid-booster-fda-approval-limits-kennedy-pfizer-moderna/758183/ https://www.biopharmadive.com/news/covid-booster-fda-approval-limits-kennedy-pfizer-moderna/758183/"  
[X Link](https://x.com/BioPharmaDive/status/1960768886862983492)  2025-08-27T18:18Z 13.5K followers, [---] engagements


"Novo strikes RNA drug deal with startup Replicate $NVO by Kristin Jensen https://www.biopharmadive.com/news/novo-replicate-self-amplifying-rna-obesity-research/758852/ https://www.biopharmadive.com/news/novo-replicate-self-amplifying-rna-obesity-research/758852/"  
[X Link](https://x.com/BioPharmaDive/status/1961102005604139478)  2025-08-28T16:22Z 13.5K followers, [---] engagements


"Novartis thinks Arrowhead brain drug can succeed where others couldnt $NVS $ARWR by @realJacobBell https://www.biopharmadive.com/news/novartis-arrowhead-parkinsons-drug-deal-license/759003/ https://www.biopharmadive.com/news/novartis-arrowhead-parkinsons-drug-deal-license/759003/"  
[X Link](https://x.com/BioPharmaDive/status/1962925408346611794)  2025-09-02T17:07Z 13.5K followers, [---] engagements


"Novartis licenses RNA drugs in deal with China-based Argo $NVS by Kristin Jensen https://www.biopharmadive.com/news/novartis-argo-licensing-deal-angptl3-rna-china/759101/ https://www.biopharmadive.com/news/novartis-argo-licensing-deal-angptl3-rna-china/759101/"  
[X Link](https://x.com/BioPharmaDive/status/1963268476488876484)  2025-09-03T15:50Z 13.5K followers, [---] engagements


"Sanofis touted eczema drug hits study goal but data fall short of expectations $SNY by Kristin Jensen https://www.biopharmadive.com/news/sanofi-amlitelimab-eczema-atopic-dermatitis-study-results-disappoint-analysts/759231/ https://www.biopharmadive.com/news/sanofi-amlitelimab-eczema-atopic-dermatitis-study-results-disappoint-analysts/759231/"  
[X Link](https://x.com/BioPharmaDive/status/1963638056155594969)  2025-09-04T16:19Z 13.5K followers, [---] engagements


"At Senate hearing lawmakers express dissatisfaction with RFK Jr.s vaccine moves by @Lilah_Alvarado @ByJonGardner https://www.biopharmadive.com/news/kennedy-rfk-senate-hearing-vaccines-cdc-crisis-acip/759319/ https://www.biopharmadive.com/news/kennedy-rfk-senate-hearing-vaccines-cdc-crisis-acip/759319/"  
[X Link](https://x.com/BioPharmaDive/status/1963699373017366602)  2025-09-04T20:23Z 13.5K followers, [---] engagements


"Bravehart a stealthy startup looks to China to challenge Bristol Myers heart drug $BMY by @BentheFidler https://www.biopharmadive.com/news/braveheart-hengrui-hypertrophic-cardiomyopathy-china-licensing-deal/759365/ https://www.biopharmadive.com/news/braveheart-hengrui-hypertrophic-cardiomyopathy-china-licensing-deal/759365/"  
[X Link](https://x.com/BioPharmaDive/status/1963983733037363486)  2025-09-05T15:13Z 13.5K followers, [---] engagements


"A UK #biotech takes aim at Parkinsons ALS by drugging mitochondria by @gwendolynawu https://www.biopharmadive.com/news/nrg-therapeutics-series-b-parkinsons-als-mitochondria-mptp/759403/ https://www.biopharmadive.com/news/nrg-therapeutics-series-b-parkinsons-als-mitochondria-mptp/759403/"  
[X Link](https://x.com/BioPharmaDive/status/1965081097261490505)  2025-09-08T15:53Z 13.5K followers, [---] engagements


"Lilly to give biotech startups access to AI tools $LLY by @gwendolynawu https://www.biopharmadive.com/news/eli-lilly-biotech-ai-tunelab-drug-discovery-startups/759630/ https://www.biopharmadive.com/news/eli-lilly-biotech-ai-tunelab-drug-discovery-startups/759630/"  
[X Link](https://x.com/BioPharmaDive/status/1965806739657531432)  2025-09-10T15:57Z 13.5K followers, [---] engagements


"Novo Nordisk to lay off [----] workers in major restructuring $NVO by Kristin Jensen https://www.biopharmadive.com/news/novo-nordisk-layoffs-restructuring-obesity-drug-competition/759748/ https://www.biopharmadive.com/news/novo-nordisk-layoffs-restructuring-obesity-drug-competition/759748/"  
[X Link](https://x.com/BioPharmaDive/status/1965817768173015294)  2025-09-10T16:40Z 13.5K followers, [---] engagements


"FDA clears J&Js drug-device combo for bladder cancer $JNJ @ByJonGardner https://www.biopharmadive.com/news/fda-inlexzo-approval-johnson-johnson-bladder-cancer/759727/ https://www.biopharmadive.com/news/fda-inlexzo-approval-johnson-johnson-bladder-cancer/759727/"  
[X Link](https://x.com/BioPharmaDive/status/1965844733798003151)  2025-09-10T18:28Z 13.5K followers, [---] engagements


"Novartis dives deeper into protein degraders with second Monte Rosa deal $NVS by @BentheFidler https://www.biopharmadive.com/news/novartis-monte-rosa-molecular-glue-degrader-partnership-immune-drugs/760084/ https://www.biopharmadive.com/news/novartis-monte-rosa-molecular-glue-degrader-partnership-immune-drugs/760084/"  
[X Link](https://x.com/BioPharmaDive/status/1967623227007811993)  2025-09-15T16:15Z 13.5K followers, [----] engagements


"Former CinCor execs reunite to helm new biotech startup by @gwendolynawu https://www.biopharmadive.com/news/allrock-bio-cincor-sanofi-rock-inhibitor/760043/ https://www.biopharmadive.com/news/allrock-bio-cincor-sanofi-rock-inhibitor/760043/"  
[X Link](https://x.com/BioPharmaDive/status/1967962912737333334)  2025-09-16T14:44Z 13.5K followers, [---] engagements


"Roivant pill succeeds in rare inflammatory disease trial $ROIV @ByJonGardner https://www.biopharmadive.com/news/roivant-pfizer-brepocitinib-trial-dermatomyositis/760368/ https://www.biopharmadive.com/news/roivant-pfizer-brepocitinib-trial-dermatomyositis/760368/"  
[X Link](https://x.com/BioPharmaDive/status/1968352861533999492)  2025-09-17T16:34Z 13.6K followers, [---] engagements


"GSK ups US investment with $30B spending plan $GSK by @NedPagliarulo https://www.biopharmadive.com/news/gsk-us-manufacturing-investment-30-billion-pennsylvania/760366/ https://www.biopharmadive.com/news/gsk-us-manufacturing-investment-30-billion-pennsylvania/760366/"  
[X Link](https://x.com/BioPharmaDive/status/1968364494591348830)  2025-09-17T17:20Z 13.6K followers, [---] engagements


"Roche dives into MASH with $2.4B deal for 89bio $RHHBY by @BentheFidler https://www.biopharmadive.com/news/roche-89bio-deal-acquire-mash-drug-fgf21-pegozafermin/760483/ https://www.biopharmadive.com/news/roche-89bio-deal-acquire-mash-drug-fgf21-pegozafermin/760483/"  
[X Link](https://x.com/BioPharmaDive/status/1968689840729280758)  2025-09-18T14:53Z 13.5K followers, [---] engagements


"Biogen to buy startup Alcyone eyeing easier delivery of RNA drugs $BIIB By Kristin Jensen https://www.biopharmadive.com/news/biogen-alcyone-acquire-drug-delivery-brain-antisense-oligonucleotides/760504/ https://www.biopharmadive.com/news/biogen-alcyone-acquire-drug-delivery-brain-antisense-oligonucleotides/760504/"  
[X Link](https://x.com/BioPharmaDive/status/1968703938951020978)  2025-09-18T15:49Z 13.6K followers, [---] engagements


"News Roundup: Arvinas reboots cuts more staff; Porges joins Lazard https://www.biopharmadive.com/news/arvinas-pfizer-out-license-porges-lazard-vertex-casgevy-italy/760567/ https://www.biopharmadive.com/news/arvinas-pfizer-out-license-porges-lazard-vertex-casgevy-italy/760567/"  
[X Link](https://x.com/BioPharmaDive/status/1969103569111470516)  2025-09-19T18:17Z 13.5K followers, [---] engagements


"CDC panel recast by RFK Jr. softens COVID vaccine recommendations $MRNA $PFE $SNY https://www.biopharmadive.com/news/acip-cdc-covid-vaccine-guidelines-coverage-prescriptions/760660/ https://www.biopharmadive.com/news/acip-cdc-covid-vaccine-guidelines-coverage-prescriptions/760660/"  
[X Link](https://x.com/BioPharmaDive/status/1969147499127456031)  2025-09-19T21:12Z 13.6K followers, [---] engagements


"As shutdown begins FDA to stop accepting new drug submissions By Kristin Jensen https://www.biopharmadive.com/news/fda-government-shutdown-new-drug-applications-reviews/761576/ https://www.biopharmadive.com/news/fda-government-shutdown-new-drug-applications-reviews/761576/"  
[X Link](https://x.com/BioPharmaDive/status/1973393152414228569)  2025-10-01T14:22Z 13.5K followers, [---] engagements


"MapLight uses workaround to tee up IPO during government shutdown by @gwendolynawu https://www.biopharmadive.com/news/maplight-ipo-terms-government-shutdown-schizophrenia-drug/802231/ https://www.biopharmadive.com/news/maplight-ipo-terms-government-shutdown-schizophrenia-drug/802231/"  
[X Link](https://x.com/BioPharmaDive/status/1975592901255254059)  2025-10-07T16:03Z 13.5K followers, [---] engagements


"Novo joins MASH dealmaking surge with $4.7B Akero buyout $NVO $AKRO @ByJonGardner https://www.biopharmadive.com/news/novo-akero-acquire-MASH-drug-efruxifermin-fgf21-89bio/802465/ https://www.biopharmadive.com/news/novo-akero-acquire-MASH-drug-efruxifermin-fgf21-89bio/802465/"  
[X Link](https://x.com/BioPharmaDive/status/1976332629751497121)  2025-10-09T17:03Z 13.5K followers, [---] engagements


"Lilly battling skepticism reinforces GLP-1 pills case with new study data $LLY By Kristin Jensen https://www.biopharmadive.com/news/orforglipron-diabetes-achieve-sglt2-study-results/802820/ https://www.biopharmadive.com/news/orforglipron-diabetes-achieve-sglt2-study-results/802820/"  
[X Link](https://x.com/BioPharmaDive/status/1978494198656467312)  2025-10-15T16:12Z 13.6K followers, [---] engagements


"A regenerative therapy for hair loss attracts a mega-fundraising round by @realJacobBell https://www.biopharmadive.com/news/pelage-hair-loss-therapy-drug-fundraise-series-b-arch-gv/802857/ https://www.biopharmadive.com/news/pelage-hair-loss-therapy-drug-fundraise-series-b-arch-gv/802857/"  
[X Link](https://x.com/BioPharmaDive/status/1978526802164215990)  2025-10-15T18:22Z 13.6K followers, [---] engagements


"Novo wagers up to $2.1B on Omeros rare disease drug $NVO $OMER by @Lilah_Alvarado https://www.statnews.com/2025/10/10/sarepta-gene-therapy-limb-girdle-muscular-dystrophy/ https://www.statnews.com/2025/10/10/sarepta-gene-therapy-limb-girdle-muscular-dystrophy/"  
[X Link](https://x.com/BioPharmaDive/status/1978538348697248161)  2025-10-15T19:07Z 13.6K followers, [---] engagements


"Novo searching for successor to CEO Srensen who oversaw huge growth and has big shoes to fill: http://t.co/Dmx7K9sAzZ $NVO http://bit.ly/1B08qdn http://bit.ly/1B08qdn"  
[X Link](https://x.com/BioPharmaDive/status/549668128062722048)  2014-12-29T20:47Z 13.3K followers, [--] engagements


"UPDATE: #Biotech indices fall more than broader markets as Dow plunges. One exception $KYTH http://t.co/PHQySQzjCO http://t.co/1ejanxzL9E http://bit.ly/1U9RxUa http://bit.ly/1U9RxUa"  
[X Link](https://x.com/BioPharmaDive/status/635917901405548544)  2015-08-24T20:53Z 13.5K followers, [--] engagements


"The "best-performing" CEO in the world is a #pharma chief: http://t.co/398Nkxz7zF $NVO $BIIB $GILD $BMY http://t.co/b5XwwwoCbP https://x.com/the_sy_guy/status/654317331347341312/photo/1 http://bit.ly/1NcLgpv https://x.com/the_sy_guy/status/654317331347341312/photo/1 http://bit.ly/1NcLgpv"  
[X Link](https://x.com/BioPharmaDive/status/654445861586509824)  2015-10-14T23:57Z 13.3K followers, [--] engagements


"Diabetes therapeutics: A hotbed of innovation and reservoir of #pharma progress http://t.co/wpp4GhDoq0 $LLY $MRK $JNJ $AZN http://bit.ly/1jDvLgb http://bit.ly/1jDvLgb"  
[X Link](https://x.com/BioPharmaDive/status/655820498824249344)  2015-10-18T18:59Z 13.3K followers, [--] engagements


"$NVO's Victoza fails the #Jardiance test doesn't improve heart outcomes in trial: $LLY #diabetes http://bit.ly/1L6EJsg http://bit.ly/1L6EJsg"  
[X Link](https://x.com/BioPharmaDive/status/663770613828333569)  2015-11-09T17:30Z 13.3K followers, [--] engagements


"Much-anticipated trial shows $NVO's Victoza reduces CV risk $LLY http://bit.ly/1QvLETk http://bit.ly/1QvLETk"  
[X Link](https://x.com/BioPharmaDive/status/706124663580073984)  2016-03-05T14:30Z 13.3K followers, [--] engagements


"Hologic's Zika test can be used on emergency basis FDA says $HOLX http://bit.ly/28IEUnr http://bit.ly/28IEUnr"  
[X Link](https://x.com/BioPharmaDive/status/744935856180367360)  2016-06-20T16:52Z 13.3K followers, [--] engagements


"$NVO CEO latest to leave in string of high-profile pharma departures this year: http://bit.ly/2c7DkdT http://bit.ly/2c7DkdT"  
[X Link](https://x.com/BioPharmaDive/status/771450329158209536)  2016-09-01T20:51Z 13.3K followers, [--] engagements


"$NVO CEO Sorensen latest #pharma chief to depart following execs from $BIIB $GILD $VRX $LLY http://bit.ly/2c7DkdT http://bit.ly/2c7DkdT"  
[X Link](https://x.com/BioPharmaDive/status/772573225666482177)  2016-09-04T23:13Z 13.3K followers, [--] engagements


"Pharma plays the blame game at the top $BIIB $VRX $NVO $LLY http://bit.ly/2cfeb18 http://bit.ly/2cfeb18"  
[X Link](https://x.com/BioPharmaDive/status/774665774573031424)  2016-09-10T17:48Z 13.3K followers, [--] engagements


"$NVO bolsters evidence for GLP-1 semaglutide http://bit.ly/2d5Oq5n http://bit.ly/2d5Oq5n"  
[X Link](https://x.com/BioPharmaDive/status/776893951542386688)  2016-09-16T21:22Z 13.3K followers, [--] engagements


"ICYM the big news from this morning $NVO is cutting [----] jobs to save costs http://bit.ly/2doUKkK http://bit.ly/2doUKkK"  
[X Link](https://x.com/BioPharmaDive/status/781610505366413312)  2016-09-29T21:44Z 13.3K followers, [--] engagements


"$NVO $LLY $SNY locked in insulin pricing wars: http://bit.ly/2e4siWn http://bit.ly/2e4siWn"  
[X Link](https://x.com/BioPharmaDive/status/786610702110724096)  2016-10-13T16:53Z 13.3K followers, [--] engagements


"Competition in insulin market heats up. Who's in the lead $SNY $NVO $LLY http://bit.ly/2e4siWn http://bit.ly/2e4siWn"  
[X Link](https://x.com/BioPharmaDive/status/787321638287085573)  2016-10-15T15:58Z 13.3K followers, [--] engagements


"FDA approves $GILD's Vemlidy though some are up in arms over its active ingredient http://bit.ly/2g2Pzwe http://bit.ly/2g2Pzwe"  
[X Link](https://x.com/BioPharmaDive/status/797180600054476800)  2016-11-11T20:54Z 13.3K followers, [--] engagements


"It's $SNY v. $NVO as FDA approves new diabetes combos http://bit.ly/2ggiuZO http://bit.ly/2ggiuZO"  
[X Link](https://x.com/BioPharmaDive/status/802907587121446912)  2016-11-27T16:11Z 13.3K followers, [--] engagements


"$NVO calls for lower drug prices joining the likes of $AGN $MYL http://bit.ly/2hgXc2z http://bit.ly/2hgXc2z"  
[X Link](https://x.com/BioPharmaDive/status/807987058958594049)  2016-12-11T16:35Z 13.3K followers, [--] engagements


"$GILD CEO gives updates on hep C business #JPM17 http://bit.ly/2jeFbQi http://bit.ly/2jeFbQi"  
[X Link](https://x.com/BioPharmaDive/status/818880339334561792)  2017-01-10T18:01Z 13.3K followers, [--] engagements


"$LLY $NVO $SNY face lawsuit over diabetes drug prices http://bit.ly/2kMjpnN http://bit.ly/2kMjpnN"  
[X Link](https://x.com/BioPharmaDive/status/828281033778925568)  2017-02-05T16:36Z 13.3K followers, [--] engagements


"#ICYMI $TMO to buy Patheon in $7.2B deal accelerating CDMO consolidation http://bit.ly/2rwnO0v http://bit.ly/2rwnO0v"  
[X Link](https://x.com/BioPharmaDive/status/865324869877080064)  2017-05-18T21:55Z 13.3K followers, [--] engagements


"$NVO seeks expanded label for Tresiba http://bit.ly/2qvXXdk http://bit.ly/2qvXXdk"  
[X Link](https://x.com/BioPharmaDive/status/871142202952622080)  2017-06-03T23:11Z 13.3K followers, [--] engagements


"$NVO's Victoza wins backing of FDA panel on CV benefit http://bit.ly/2tT3Z4N http://bit.ly/2tT3Z4N"  
[X Link](https://x.com/BioPharmaDive/status/877963904571252737)  2017-06-22T18:58Z 13.3K followers, [--] engagements


"Endocrinologic and Metabolic Drugs Advisory Committee backs $NVO's diabetes drug Victoza http://bit.ly/2tT3Z4N http://bit.ly/2tT3Z4N"  
[X Link](https://x.com/BioPharmaDive/status/878025308384800769)  2017-06-22T23:02Z 13.3K followers, [--] engagements


"$AGMN $NVS disclose PDUFA date brand name for erenumab http://bit.ly/2vIjCgf http://bit.ly/2vIjCgf"  
[X Link](https://x.com/BioPharmaDive/status/888499577057423360)  2017-07-21T20:43Z 13.5K followers, [--] engagements


"$NVO settles claims related to Victoza marketing http://bit.ly/2f3Mgmc http://bit.ly/2f3Mgmc"  
[X Link](https://x.com/BioPharmaDive/status/905456460649418752)  2017-09-06T15:43Z 13.3K followers, [--] engagements


"Janssen Biotech president Scott White: "There is no merit to this lawsuit." $JNJ $PFE http://bit.ly/2wGMFkB http://bit.ly/2wGMFkB"  
[X Link](https://x.com/BioPharmaDive/status/910621340499156993)  2017-09-20T21:47Z 13.3K followers, [--] engagements


"Former $AGMN exec Thomas Dittrich joins $SHPG as CFO http://bit.ly/2hHc6NJ http://bit.ly/2hHc6NJ"  
[X Link](https://x.com/BioPharmaDive/status/934160948641914881)  2017-11-24T20:45Z 13.5K followers, [--] engagements


"BioPharma Dive's pick for Pharma of the Year: AbbVie $ABBV http://bit.ly/2AsnaZI http://bit.ly/2AsnaZI"  
[X Link](https://x.com/BioPharmaDive/status/938089844030562304)  2017-12-05T16:57Z 13.3K followers, [--] engagements


"Pershing expects the settling costs will reduce its net asset value by [---] basis points $VRX http://bit.ly/2EDSVi8 http://bit.ly/2EDSVi8"  
[X Link](https://x.com/BioPharmaDive/status/948324273671860226)  2018-01-02T22:45Z 13.3K followers, [--] engagements


"Deals terms hold that $PFE will pay $SGMO $12M upfront and as much as $150M in milestone payments http://bit.ly/2ENE5FM http://bit.ly/2ENE5FM"  
[X Link](https://x.com/BioPharmaDive/status/948689177704521728)  2018-01-03T22:55Z 13.3K followers, [--] engagements


"$REGN's Eylea has proven to be a tough competitor in the eye disease market fetching several billion dollars worldwide annually $RHHBY http://bit.ly/2sq9Z9s http://bit.ly/2sq9Z9s"  
[X Link](https://x.com/BioPharmaDive/status/963143168513339392)  2018-02-12T20:10Z 13.3K followers, [--] engagements


"Biohaven teams up with $CTLT on CGRP oral drug delivery $BHVN http://bit.ly/2EWF6hM http://bit.ly/2EWF6hM"  
[X Link](https://x.com/BioPharmaDive/status/966799511120240640)  2018-02-22T22:19Z 13.3K followers, [--] engagements


"$IQV estimates developed markets will shell out $318B on specialty meds in [----] representing 41% of their overall pharmaceutical spend http://bit.ly/2Doy948 http://bit.ly/2Doy948"  
[X Link](https://x.com/BioPharmaDive/status/973677080733872128)  2018-03-13T21:48Z 13.3K followers, [--] engagements


"ICYMI: Chapter closing on #obesity drugs with bankruptcy filing for $OREX https://www.biopharmadive.com/news/orexigen-bankruptcy-asset-contrave-obesity/518914/ https://www.biopharmadive.com/news/orexigen-bankruptcy-asset-contrave-obesity/518914/"  
[X Link](https://x.com/BioPharmaDive/status/974011533498855424)  2018-03-14T19:57Z 13.5K followers, [--] engagements


"$NVO announces positive topline Phase [--] results for once-daily semaglutide injections in obese patients without diabetes as it continues to move into the #obesity market https://www.biopharmadive.com/news/novo-takes-aim-at-obesity-with-positive-semaglutide-results/519439/ https://www.biopharmadive.com/news/novo-takes-aim-at-obesity-with-positive-semaglutide-results/519439/"  
[X Link](https://x.com/BioPharmaDive/status/975781311309930496)  2018-03-19T17:09Z 13.3K followers, [--] engagements


"$NVO setting its sights on treating obesity as semaglutide clears another mid-stage study https://www.biopharmadive.com/news/novo-takes-aim-at-obesity-with-positive-semaglutide-results/519439/ https://www.biopharmadive.com/news/novo-takes-aim-at-obesity-with-positive-semaglutide-results/519439/"  
[X Link](https://x.com/BioPharmaDive/status/975824479447220229)  2018-03-19T20:01Z 13.3K followers, [--] engagements


"Drugs from $CELG $NVO and $JNJ also made the list http://bit.ly/2DNdx5L http://bit.ly/2DNdx5L"  
[X Link](https://x.com/BioPharmaDive/status/977530721936920581)  2018-03-24T13:01Z 13.3K followers, [--] engagements


"Walmart reportedly in early talks to acquire $HUM http://bit.ly/2Imhmlc http://bit.ly/2Imhmlc"  
[X Link](https://x.com/BioPharmaDive/status/980855631891480576)  2018-04-02T17:13Z 13.3K followers, [--] engagements


"$UTHR nabs competing PAH drug with $216M SteadyMed buy $STDY http://bit.ly/2r8oziG http://bit.ly/2r8oziG"  
[X Link](https://x.com/BioPharmaDive/status/990994438083227648)  2018-04-30T16:41Z 13.4K followers, [--] engagements


"Seeing the writing on the wall with $STDY's Trevyent $UTHR chose to acquire the biotech rather than compete on the marketplace http://bit.ly/2r8oziG http://bit.ly/2r8oziG"  
[X Link](https://x.com/BioPharmaDive/status/991071948263194625)  2018-04-30T21:49Z 13.4K followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing